Dynamic Technology Lab Private LTD Clovis Oncology, Inc. Transaction History

Dynamic Technology Lab Private LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$1.43 - $3.14 $55,755 - $122,428	-38,990 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$2.7 - $4.76 $105,273 - $185,592	38,990 New	38,990 $106,000
Q2 2021 Aug 13, 2021	SELL	$5.02 - $7.05 $58,749 - $82,506	-11,703 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$4.81 - $10.34 $56,291 - $121,009	11,703 New	11,703 $82,000
Q4 2020 Feb 11, 2021	SELL	$4.13 - $6.41 $94,490 - $146,654	-22,879 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$4.82 - $7.72 $110,276 - $176,625	22,879 New	22,879 $133,000

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Dynamic Technology Lab Private LTD, based on Form 13F filings with the SEC.

Stay updated on Dynamic Technology Lab Private LTD with notifications on news.